PER 13.0% 13.0¢ percheron therapeutics limited

interest in antisense technology is growing ,...im sure that...

  1. 173 Posts.
    lightbulb Created with Sketch. 37
    interest in antisense technology is growing ,...im sure that there will be high interest in ANP if phase 2 trial is positive .LOVE IT especially the brutally low valuation of $ 22 million .

    “2019 could be seen in years to come as the start of a new era for RNA therapeutics.”
    https://wxpress.wuxiapptec.com/rna-focused-drug-development-emerging-as-a-dominant-treatment-modality-2/


    Ultragenyx snags option on antisense startup GeneTx
    https://www.fiercebiotech.com/biotech/ultragenyx-snags-option-antisense-startup-genetx


    J&J bets billions on RNA interference..
    https://www.biopharmadive.com/news/jj-bets-billions-on-rna-interference/538908/
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.